Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Rigel Pharmaceuticals Total Current Assets 2010-2024 | RIGL

Rigel Pharmaceuticals total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  
Rigel Pharmaceuticals Annual Total Current Assets
(Millions of US $)
2024 $135
2023 $99
2022 $116
2021 $154
2020 $89
2019 $119
2018 $137
2017 $117
2016 $76
2015 $129
2014 $151
2013 $220
2012 $302
2011 $250
2010 $180
2009 $136
Rigel Pharmaceuticals Quarterly Total Current Assets
(Millions of US $)
2024-12-31 $135
2024-09-30 $106
2024-06-30 $95
2024-03-31 $92
2023-12-31 $99
2023-09-30 $95
2023-06-30 $101
2023-03-31 $107
2022-12-31 $116
2022-09-30 $110
2022-06-30 $121
2022-03-31 $139
2021-12-31 $154
2021-09-30 $171
2021-06-30 $184
2021-03-31 $197
2020-12-31 $89
2020-09-30 $100
2020-06-30 $113
2020-03-31 $116
2019-12-31 $119
2019-09-30 $126
2019-06-30 $125
2019-03-31 $139
2018-12-31 $137
2018-09-30 $121
2018-06-30 $139
2018-03-31 $97
2017-12-31 $117
2017-09-30 $70
2017-06-30 $84
2017-03-31 $100
2016-12-31 $76
2016-09-30 $87
2016-06-30 $97
2016-03-31 $106
2015-12-31 $129
2015-09-30 $136
2015-06-30 $146
2015-03-31 $163
2014-12-31 $151
2014-09-30 $159
2014-06-30 $178
2014-03-31 $198
2013-12-31 $220
2013-09-30 $233
2013-06-30 $255
2013-03-31 $275
2012-12-31 $302
2012-09-30 $187
2012-06-30 $206
2012-03-31 $226
2011-12-31 $250
2011-09-30 $269
2011-06-30 $283
2011-03-31 $158
2010-12-31 $180
2010-09-30 $195
2010-06-30 $190
2010-03-31 $212
2009-12-31 $136
2009-09-30 $159
2009-06-30 $83
2009-03-31 $108
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.341B $0.179B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $99.323B 37.26
Zoetis (ZTS) United States $70.523B 26.70
Daiichi Sankyo, - (DSNKY) Japan $49.922B 25.40
Takeda Pharmaceutical (TAK) Japan $48.938B 10.83
Summit Therapeutics (SMMT) United States $20.810B 0.00
Sandoz Group AG (SDZNY) Switzerland $19.664B 0.00
Merck (MKKGY) Germany $18.359B 15.19
Shionogi (SGIOY) Japan $14.547B 14.57
United Therapeutics (UTHR) United States $13.473B 11.92
Neurocrine Biosciences (NBIX) United States $10.858B 37.20
IPSEN (IPSEY) France $9.940B 0.00
Orion OYJ (ORINY) Finland $9.075B 24.54
Corcept Therapeutics (CORT) United States $7.841B 63.74
Madrigal Pharmaceuticals (MDGL) United States $6.803B 0.00
Stevanato Group S.p.A (STVN) Italy $6.702B 42.56
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.355B 0.00
Grifols, S.A (GRFS) Spain $5.122B 0.00
Soleno Therapeutics (SLNO) United States $3.817B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.151B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.964B 12.03
Hypermarcas (HYPMY) Brazil $2.350B 15.46
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.337B 12.78
BioCryst Pharmaceuticals (BCRX) United States $2.308B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.223B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.911B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.807B 0.00
Indivior (INDV) United States $1.641B 6.96
Guardian Pharmacy Services (GRDN) United States $1.610B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
ARS Pharmaceuticals (SPRY) United States $1.400B 178.25
Dyne Therapeutics (DYN) United States $1.344B 0.00
Ocular Therapeutix (OCUL) United States $1.231B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.129B 45.89
Enliven Therapeutics (ELVN) United States $1.000B 0.00
Harrow (HROW) United States $0.907B 0.00
Ardelyx (ARDX) United States $0.894B 0.00
Collegium Pharmaceutical (COLL) United States $0.893B 4.74
Avadel Pharmaceuticals (AVDL) Ireland $0.874B 0.00
Xencor (XNCR) United States $0.763B 0.00
AleAnna (ANNA) United States $0.743B 0.00
Cronos Group (CRON) Canada $0.732B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Organogenesis (ORGO) United States $0.675B 0.00
KalVista Pharmaceuticals (KALV) United States $0.651B 0.00
Akebia Therapeutics (AKBA) United States $0.613B 0.00
Bioventus (BVS) United States $0.576B 14.96
Savara (SVRA) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
USANA Health Sciences (USNA) United States $0.546B 11.71
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.515B 0.00
CytoDyn (CYDY) United States $0.511B 0.00
Verve Therapeutics (VERV) United States $0.460B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.459B 0.00
Elite Pharmaceuticals (ELTP) United States $0.455B 0.00
Zevra Therapeutics (ZVRA) United States $0.437B 0.00
Altimmune (ALT) United States $0.418B 0.00
Tourmaline Bio (TRML) United States $0.409B 0.00
Siga Technologies (SIGA) United States $0.386B 6.59
Oruka Therapeutics (ORKA) United States $0.374B 0.00
Heron Therapeutics (HRTX) United States $0.325B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
Wellgistics Health (WGRX) United States $0.237B 0.00
Nature's Sunshine Products (NATR) United States $0.231B 27.17
ProKidney (PROK) United States $0.220B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 26.25
OmniAb (OABI) United States $0.205B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.167B 0.00
Korro Bio (KRRO) United States $0.166B 0.00
4D Molecular Therapeutics (FDMT) United States $0.165B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.150B 46.38
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Nektar Therapeutics (NKTR) United States $0.128B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.126B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.116B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.68
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Cassava Sciences (SAVA) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Karyopharm Therapeutics (KPTI) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.019B 7.60
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.14
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00